255 related articles for article (PubMed ID: 17522440)
1. Proteomics analysis of the Alzheimer's disease hippocampal proteome.
Sultana R; Boyd-Kimball D; Cai J; Pierce WM; Klein JB; Merchant M; Butterfield DA
J Alzheimers Dis; 2007 May; 11(2):153-64. PubMed ID: 17522440
[TBL] [Abstract][Full Text] [Related]
2. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Merchant M; Markesbery WR; Butterfield DA
Neurobiol Aging; 2006 Nov; 27(11):1564-76. PubMed ID: 16271804
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Analysis of Protein Expression Throughout Disease Progression in a Mouse Model of Alzheimer's Disease.
Fu Y; Zhao D; Pan B; Wang J; Cui Y; Shi F; Wang C; Yin X; Zhou X; Yang L
J Alzheimers Dis; 2015; 47(4):915-26. PubMed ID: 26401771
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.
Butterfield DA; Perluigi M; Sultana R
Eur J Pharmacol; 2006 Sep; 545(1):39-50. PubMed ID: 16860790
[TBL] [Abstract][Full Text] [Related]
5. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.
Butterfield DA; Poon HF; St Clair D; Keller JN; Pierce WM; Klein JB; Markesbery WR
Neurobiol Dis; 2006 May; 22(2):223-32. PubMed ID: 16466929
[TBL] [Abstract][Full Text] [Related]
6. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.
Castegna A; Aksenov M; Thongboonkerd V; Klein JB; Pierce WM; Booze R; Markesbery WR; Butterfield DA
J Neurochem; 2002 Sep; 82(6):1524-32. PubMed ID: 12354300
[TBL] [Abstract][Full Text] [Related]
7. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis.
Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Markesbery WR; Zhou XZ; Lu KP; Butterfield DA
Neurobiol Aging; 2006 Jul; 27(7):918-25. PubMed ID: 15950321
[TBL] [Abstract][Full Text] [Related]
8. Differential S-nitrosylation of proteins in Alzheimer's disease.
Zahid S; Khan R; Oellerich M; Ahmed N; Asif AR
Neuroscience; 2014 Jan; 256():126-36. PubMed ID: 24157928
[TBL] [Abstract][Full Text] [Related]
9. Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
Owen JB; Di Domenico F; Sultana R; Perluigi M; Cini C; Pierce WM; Butterfield DA
J Proteome Res; 2009 Feb; 8(2):471-82. PubMed ID: 19072283
[TBL] [Abstract][Full Text] [Related]
10. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI.
Aluise CD; Robinson RA; Cai J; Pierce WM; Markesbery WR; Butterfield DA
J Alzheimers Dis; 2011; 23(2):257-69. PubMed ID: 20930294
[TBL] [Abstract][Full Text] [Related]
11. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
12. Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.
Blennow K; Bogdanovic N; Alafuzoff I; Ekman R; Davidsson P
J Neural Transm (Vienna); 1996; 103(5):603-18. PubMed ID: 8811505
[TBL] [Abstract][Full Text] [Related]
13. Targeted quantitative analysis of synaptic proteins in Alzheimer's disease brain.
Chang RY; Etheridge N; Dodd PR; Nouwens AS
Neurochem Int; 2014 Sep; 75():66-75. PubMed ID: 24893329
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
15. Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.
Triplett JC; Swomley AM; Cai J; Klein JB; Butterfield DA
J Alzheimers Dis; 2016; 49(1):45-62. PubMed ID: 26444780
[TBL] [Abstract][Full Text] [Related]
16. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases.
Muramori F; Kobayashi K; Nakamura I
Psychiatry Clin Neurosci; 1998 Dec; 52(6):593-9. PubMed ID: 9895207
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms implicated in protein changes in the Alzheimer's disease human hippocampus.
Nguyen HD; Kim WK; Huong Vu G
Mech Ageing Dev; 2024 Jun; 219():111930. PubMed ID: 38554950
[TBL] [Abstract][Full Text] [Related]
18. Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology.
Zolochevska O; Bjorklund N; Woltjer R; Wiktorowicz JE; Taglialatela G
J Alzheimers Dis; 2018; 65(2):659-682. PubMed ID: 30103319
[TBL] [Abstract][Full Text] [Related]
19. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach.
Sultana R; Poon HF; Cai J; Pierce WM; Merchant M; Klein JB; Markesbery WR; Butterfield DA
Neurobiol Dis; 2006 Apr; 22(1):76-87. PubMed ID: 16378731
[TBL] [Abstract][Full Text] [Related]
20. Neurons and extracellular neurofibrillary tangles in the hippocampal subdivisions in early-onset familial Alzheimer's disease: a case study.
Fukutani Y; Sasaki K; Mukai M; Matsubara R; Isaki K; Cairns NJ
Psychiatry Clin Neurosci; 1997 Aug; 51(4):227-31. PubMed ID: 9316169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
